News Update

SRL Diagnostics Acquires Lifeline Laboratory to Expand Presence in Indian Pathology Market

• ByStartupStory     |    April 11, 2023

SRL Diagnostics, a subsidiary of Fortis Healthcare, a Mumbai-listed hospital chain, has acquired Lifeline Laboratory to expand its presence in the Indian pathology market. According to media reports, SRL’s acquisition of Delhi-based Lifeline is expected to accelerate its growth and broaden its geographic reach.

“Lifeline will benefit tremendously from SRL’s industry-leading distribution network and operational efficiencies while SRL gets an incredible NCR-focused brand that stands for quality and service,” said Manmohan Tiwana, Managing Director and CEO, Wodehouse Capital.

According to reports, this transaction will expand SRL’s footprint in Delhi and help it expand its presence in key markets such as Mumbai, Uttar Pradesh, Andhra Pradesh, and Telangana.

“I am confident that Lifeline shall have a wider market reach and recall in an otherwise crowded segment,” said Angeli Misra, Partner, Lifeline Laboratory.

SRL operates over 400 laboratories and over 9,000 collection centres. It claims to perform more than 100,000 tests per day and offers 3,500 different tests in pathology, radiology, wellness, occupational health, and clinical trials.

Calling all entrepreneurs, investors and business owners! The wait is finally over. The 2nd edition of Startup Story B2B Connect is back with a bang – and this time, we’re taking it up a notch. With more startups, more investors and bigger opportunities than ever before, this is your chance to connect, collaborate and take your business to the next level. Get ready for an unforgettable networking experience that’s set to change the game. Stay tuned for all the exciting updates! Register Now Here.

Follow Startup Story